Kevin J. Downes, MD

Staff Physician, Division of Infectious Diseases

Clinical Fellow, Division of Clinical Pharmacology

Phone 513-636-3511



Pediatric infectious diseases


Antimicrobial clinical pharmacology; acute kidney injury; cystic fibrosis

MD: University of Pennsylvania School of Medicine, Philadelphia, PA, 2008.

Residency: Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2011.

Fellowship: Pediatric Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2014; Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2014.

Certification: Pediatrics, 2011.

View PubMed Publications

Shah SS, Downes KJ, Elliott MR, Bell LM, McGowan KL, Metlay JP. How long does it take to “rule out” bacteremia in children with central venous catheters? Pediatrics. 2008 Jan; 121(1): 135-41.

Downes KJ, Metlay JP, Bell LM, McGowan KL, Elliott MR, Shah SS. Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care. Clin Infect Dis. 2008 Feb 1; 46(3): 387-94.

Downes KJ, Hahn A, Wiles J, Courter JD, Vinks AA. Dose optimisation of antibiotics in children: the application of pharmacokinetics/pharmacodynamics in paediatrics. Int J Antimicrob Agents. 2014 Mar;43(3):223-30.

Downes KJ, Rao MB, Kahill L, Nguyen H, Clancy JP, Goldstein SL. Daily serum creatinine monitoring promotes earlier detection of acute kidney injury in children and adolescents with cystic fibrosis. J Cyst Fibros. 2014 Jul;13(4):435-41.

Urinary biomarkers for aminoglycoside-associated acute kidney injury in Cystic Fibrosis. Principal Investigator. Thrasher Research Fund Early Career Award Program Grant. Oct 2012-Sept 2014.